About Enhancer
| Enhancer ID: |
E_02_0041 |
| Species: |
human |
| Position :
|
chr7:148804484-148806484
  |
| Biosample name: |
|
| Experiment class :
|
High+Lowthroughput |
| Enhancer type: |
Enhancer |
| Disease: |
Liver fibrosis |
| Pubmed ID: |
28970250
|
| Enhancer experiment: |
Western blot, qPCR,Transfection,ChIP |
| Enhancer experiment description: |
Finally, EZH2 inhibition or PPARg activation ameliorated fibrogenesis in cKO mice. |
About Target gene
| Target gene : |
EZH2 |
| Strong evidence: |
qRT-PCR,qPCR,ChIP,3C |
| Less strong evidence: |
RNA-Seq |
| Target gene experiment description: |
Finally, EZH2 inhibition or PPARg activation ameliorated fibrogenesis in cKO mice. |
About TF
| TF name : |
-- |
| TF experiment: |
Western blot, qPCR,Transfection,ChIP |
| TF experiment description: |
Finally, EZH2 inhibition or PPARg activation ameliorated fibrogenesis in cKO mice. |
About Function
| Enhancer function : |
Finally, EZH2 inhibition or PPARg activation ameliorated fibrogenesis in cKO mice. |
| Enhancer function experiment: |
Immunohistochemical staining |
Enhancer function
experiment description: |
Finally, EZH2 inhibition or PPARg activation ameliorated fibrogenesis in cKO mice. |
About SNP
Upstream Pathway Annotation of TF
Enhancer associated network
The number on yellow line represents the distance between enhancer and
target gene
Expression of target genes for the
enhancer
Enhancer associated SNPs